Adrenal incidentalomas have recently increased in incidence, and thus it has become important to establish clinical management of these patients. It is also important to evaluate whether these tumors are different from preclinical or overt Cushing's syndrome in their steroidogenesis.
The incidence of adrenal incidentaloma has recently been increasing due to the widespread use of diagnostic techniques, such as ultrasonography, computed tomography (CT) and magnetic resonance (MR) imaging.
The reported incidence of incidentaloma ranges from 0.6 to 3.4% [1] [2] [3] [4] . Most cases of adrenal Incidentaloma have been reported to be nonfunctioning tumors or hormonally inactive adrenal tumors, but some cases (5-12%) have been associated with clinically significant autonomous cortisol secretion sufficient to alter the hypothalamopituitary-adrenal (HPA) axis. These cases were termed preclinical Cushing's or pre-Cushing's syndrome following detailed endocrinological examinations [4] [5] [6] . Clinically silent or hormonally inactive adrenocortical tumors have been demonstrated to be associated with various degrees of steroidogenesis [7, 8] . The long-term clinical course of patients with this tumor still remains controversial, partly due to the lack of long-term clinical follow-up studies [9] . Therefore, the clinical management of these adrenal incidentalomas, especially the criteria for surgical resection of these neoplasms, has yet to be determined.
Several groups of investigators have provided evidence suggesting the presence of steroidogenesis in hormonally inactive adrenal tumors by utilizing numerous study methods, including the analysis of steroid content in tumor tissues, enzyme activity, immunohistochemistry of steroidogenic enzymes, and dispersed adrenal cell studies [6, 7, 10, 11] . However, few studies have examined in vitro steroidogenesis or actual output of corticosteroids from tumor cells and the expression of steroidogenic enzymes in these tumors.
Therefore, in this study, we examined in vitro steroidogenesis of adrenal tumors during short-term culture of tissue slices. In addition, we investigated the immunohistochemical expression of steroidogenic enzymes in these cultured adrenal tumors to examine features of steroidogenesis of hormonally inactive adrenal tumors.
We then compared these findings with preclinical Cushing's syndrome and overt Cushing's syndrome in an effort to elucidate the characteristics of steroidogenesis in these cases.
Patients
Five patients, two men and three women, aged 43-71 years old, with hormonally inactive incidentally discovered adrenal tumors were examined in this study. The clinical history and characteristics of these patients are summarized in Table 1 . Three cases with preclinical Cushing's syndrome and three cases with overt Cushing's syndrome were also examined. Except for hypertension (n = 3), disturbed glucose tolerance (n=4) and general obesity (n=2), none of the patients diagnosed with incidentalomas had any specific clinical or hormonal signs for adrenal steroid excess, nor had they been treated with antihypertensive drugs, insulin or oral antihyperglycemic agents.
The results of endocrinological examination are summarized in Tables 2 and 3 . Plasma ACTH, serum cortisol, plasma renin activity (PRA), plasma aldosterone (PAC), and urinary extraction of 17-OHCS and 17-KS were within normal limits in patients with hormonally inactive adrenal tumors. The circadian rhythm of serum cortisol and plasma ACTH was evaluated with blood sampling every 4 h over a 24-h period. Plasma ACTH and serum cortisol had normal circadian rhythms in all cases. Serum DHEA-S levels were relatively low for their age. A CRH loading test was performed as follows; after a bolus intravenous injection of 100 ig of human However, insufficient or no suppression of cortisol was detected in patients with preclinical Cushing's or Cushing's syndrome. Adrenal scintillation scans using 131I-adosterol following a 2 mg dexamethasone treatment for ten days was performed in all patients. Accumulation of the Table   2 . Endocrinological findings of patients (1) tracer was discovered in the tumors, whereas no accumulation of the tracer was found in the contralateral adrenals (data not shown).
Tumors in these patients, examined by CT scan imaging, ranged from 1.5-4.5 cm in diameter. These hormonally inactive adrenal tumors were resected because of their size (greater than 3.0 cm in diameter, case No. 1, 2 and 4), or because of their increasing size (case No. 3), or patient's desire (case No. 3 and 5). Resected tumors were histologically diagnosed as adrenocortical adenomas (Table 1) . Following adrenalectomy, the blood pressure in hypertensive patients decreased.
In one patient, we observed that the levels of plasma glucose during an oral glucose tolerance test improved from that of a diabetic pattern to that of impaired glucose tolerance.
The body mass index (BMI) in this patient did not change. None of the patients had received glucocorticoid replacement following adrenalectomy. Moreover, no symptoms of adrenal failure were observed following surgery in patients diagnosed with hormonally inactive adrenocortical tumors.
Methods

In vitro steroidogenesis
Details of the methods employed in this study have been previously described [14, 15] . Adrenal tumor specimens were divided into tumor and non-tumor regions, each sectioned into small pieces with scissors. These tissues were preincubated for 1 hr in Krebs-Ringer bicarbonate medium containing 0.2% glucose in a 5% CO2 atmosphere at 37°C with continuous shaking.
The media was subsequently replaced with 5 ml of the same solution, containing ACTH (10_8 M), and then further incubated for 2 hr. Following incubation, the levels of various steroids in the medium were determined with a specific radioimmunoassay (RIA) kit. Cortisol and aldosterone concentrations were determined using a SPAC-S Cortisol kit (Daiichi Isotope Co. Ltd., Tokyo, Japan), and an aldosterone RIA kit (Dainabot Co. Ltd., Tokyo, Japan), respectively, whereas dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), and androstenedione concentration values were obtained utilizing RIA kits obtained from Mitsubishi-Kagaku Co. Ltd. Tokyo, Japan.
17-hydroxyprogesterone concentrations were measured using a RIA kit (Japan DPC Co. Ltd., Tokyo, Japan).
The production capacity for each steroid hormone was calculated per unit of tissue weight (ng or pg). Adrenal glands that were utilized as control (normal) specimens in our study were obtained from five patients with renal cell carcinoma, and from three patients diagnosed with preclinical Cushing's syndrome, and three patients with overt Cushing's syndrome, respectively.
Statistical analysis
Statistical analysis was performed utilizing a paired or unpaired Student's t-test. A p-value less than 0.05 was considered significant.
Immunohistochemical study
Immunohistochemical studies of steroidogenic enzymes, including cholesterol side chain cleavage (P450scc), 3j3-hydroxysteroid dehydrogenase (39-HSD), 21-hydroxylase (P450c21), 17a-hydroxylase (P450c 17), 11 9-hydroxylase (P45011), and dehydroepiandrosterone sulfotransferase (DHEA-ST) were performed with formalin-fixed, paraffin-embedded serial sections of tumors using the biotin-streptavidin amplified method and the Histofine immunostaining system (Nichirei Co. Ltd., Tokyo, Japan). Immunostaining procedures and characteristics of primary antibodies used in this study have been described previously by the authors [16, 17] . Phosphate buffered saline (0.01 mol/1) and normal rabbit IgG were used instead of primary antibodies as negative controls.
Results
Pathological findings
The cut surface of the tumors appeared yellow to light tan in all cases without any foci of hemorrhage and/or necrosis. The tumor was predominantly composed of clear cortical cells (almost all in cases 1 and 5, 80-90% in case 3, 70-80% in cases 2 and 4). Neither nuclear atypia nor mitosis was detected in these tumors, and all were diagnosed as adrenocorti-cal adenomas.
Attached nonneoplastic adrenals were atrophic in cases 1, 2, and 3, but were not atrophic in cases 4 and 5 (data not shown).
tumors (Table 4) .
Immunohistochemistry of steroidogenic enzymes
In vitro steroidogenesis Table 4 summarizes the results of in vitro steroidogenesis in the adrenal tumor tissue slices grown in short-term culture. Basal secretion of cortisol varied markedly compared to values in normal adrenals, which were significantly higher in cases 3 and 5 (p < 0.01), and lower in case 4 (p < 0.01). The pattern of secretion of cortisol in the hormonally mnactive tumor was not different from that of preclinical and overt Cushing's syndrome.
Relative to control levels, ACTH-stimulated cortisol secretion was significantly greater in case 4, and in one case of preclinical Cushing's syndrome, but secretion in other cases of hormonally inactive and preclinical Cushing's syndrome and all cases of Cushing's syndrome did not change ( Table 4 ). The secretion pattern for progesterone and 17-hydroxyprogesterone was similar to that of cortisol (Table 4 ). In contrast, there were no variations in the synthesis of mineralocorticoids or adrenal androgens in any of the Results of steroidogenic enzyme immunohistochemistry are summarized in Table 5 . Immunoreactivity for P450scc, 3p-HSD, P450c21, and P450c17, enzymes of which are required for cortisol production, was detected in all tumor tissues as in preclinical Cushing's or Cushing's syndrome. There were no apparent differences in the patterns of immunolocalization of steroidogenic enzymes between adrenocortical incidentalomas and tumors with preclinical and/or overt Cushing's syndrome. DHEA-ST immunoreactivity was almost undetectable in tumor lesions, but was present in all attachment nonneoplastic adrenals, except for one patient (case 3), in whom suppression of the HPA axis was detected.
The pattern of DHEA-ST immunoreactivity in the adjacent nonneoplastic adrenal in case 3 was similar to that in preclinical Cushing's or Cushing's syndrome (Table 5) . Table 4 .
Secretion of cortisol from cultured tissues
Discussion
Recently, adrenal incidentalomas have been increasing in number because of the development of imaging technologies such as CT scanning, ultrasonography and MR imaging [1] [2] [3] [4] 18] . The great majority of patients diagnosed with adrenal incidentaloma have had no associated clinical signs and symptoms suggestive of adrenocortical dysfunction. Therefore, many patients with these tumors have been diagnosed to have hormonally inactive adrenal tumors without any further detailed endocrinological examinations. It has become increasingly difficult to determine whether these tumors should be resected or not. In addition, it is unclear whether these tumors may develop preclinical or clinically overt Cushing's syndrome in their clinical course, if left untreated.
In this study, we examined five cases of hormonally inactive adrenal tumors that have been diagnosed utilizing a detailed endocrinological examination including a dexamethasone suppression test. Enzymes involved in cortisol production were immunolocalized in tumor tissues in all cases examined. Expression patterns of these enzymes were found to be not different from tumors of preclinical or overt Cushing's syndrome. In addition, the secretion of cortisol from hormonally inactive adrenocortical tumors was demonstrated to vary markedly compared to normal adrenal glands studied as controls. In addition, the response to ACTH stimulation in these patients also varied markedly. The levels of cortisol secretion from these tumors were similar to those of preclinical and overt Cushing's syndrome. These results suggest that hormonally inactive adrenocortical incidentalomas have the capacity of producing cortisol as in tumors with preclinical or overt Cushing's syndrome. In addition, immunohistochemical patterns of steroidogenic enzyme expression, as well as steroid secretion patterns varied markedly among the cases of incidentaloma studied.
In cases where tumors were associated with elevated in vitro cortisol secretion, the following characteristics were noted: 1) the concentrations of adrenal androgen, especially DHEA-S, were low compared with other steroids, 2) there was no ACTH-induced secretion of cortisol, 3) the presence of cortical atrophy in the nonneoplastic adjacent adrenal gland, and 4) the absence of DHEA-ST in the nonneoplastic adrenal gland. It is known that DHEA-ST is regulated by ACTH. Recently, it has been reported that immunolocalization of DHEA-ST in a nonneoplastic adjacent adrenal gland shows a similar degree of suppression as in the pituitary-adrenal axis [19] . In Table 5 .
Immunohistochemical findings of the tumors case 3, no DHEA-ST immunoreactivity was detected in the nonneoplastic adjacent adrenal gland. The four characteristics described above suggest that there is suppression of the pituitary-adrenal axis, but not sufficient to detect the suppression by dexamethasone suppression test, as in Cushing's syndrome. It is also important to note that the in vitro shortterm culture of tissue slices employed in this study may not indicate whether these tumors autonomously produce and secrete cortisol. The in vitro effects of ACTH on corticosteroid secretion are influenced not only by the level of ACTH receptor expression, but also by the level of steroidogenic enzyme expression. Therefore, the similarity of in vitro corticosteroid secretion features and immunolocalization patterns of steroidogenic enzymes between hormonally inactive incidentaloma and preclinical or overt Cushing's syndrome by no means indicate that corticosteroid production and/or secretion from hormonally inactive adrenocortical incidentaloma are not different from those of preclinical and/or overt Cushing's adenoma. Further investigations, including analysis of the quantitative expression of steroidogenic enzymes, are required to clarify the role of these steroidogenic enzymes in the physiology and possible pathogenesis of hormonally inactive adrenocortical incidentaloma.
Hypertension and disturbed glucose tolerance are often associated with adrenal incidentaloma. These symptoms are considered not to be specific complications of adrenal incidentaloma, but the high prevalence of hypertension and disturbed glucose tolerance in these patients compared to the normal population have been reported [20] [21] [22] .
In our study, we found that our patients had a high incidence of both hypertension and disturbed glucose tolerance, and furthermore these symptoms improved following adrenalectomy. Further examinations are required to investigate that some adrenal incidentalomas may affect the metabolic state of the adrenals, even if they are identified as being hormonally inactive adrenocortical tumors.
